Exagen (XGN) Total Non-Current Liabilities (2018 - 2026)
Exagen filings provide 9 years of Total Non-Current Liabilities readings, the most recent being $36.8 million for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 8.85% to $36.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $36.8 million, a 8.85% increase, with the full-year FY2025 number at $38.8 million, up 10.45% from a year prior.
- Total Non-Current Liabilities hit $36.8 million in Q1 2026 for Exagen, down from $38.8 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $45.1 million in Q1 2022 to a low of $30.5 million in Q1 2024.
- Median Total Non-Current Liabilities over the past 5 years was $35.1 million (2024), compared with a mean of $36.8 million.
- Biggest five-year swings in Total Non-Current Liabilities: increased 29.28% in 2022 and later fell 28.24% in 2024.
- Exagen's Total Non-Current Liabilities stood at $42.9 million in 2022, then decreased by 20.98% to $33.9 million in 2023, then rose by 3.71% to $35.1 million in 2024, then increased by 10.45% to $38.8 million in 2025, then decreased by 5.31% to $36.8 million in 2026.
- The last three reported values for Total Non-Current Liabilities were $36.8 million (Q1 2026), $38.8 million (Q4 2025), and $38.1 million (Q3 2025) per Business Quant data.